Research and Markets -- Pen Needles Market Worth USD 2.81 Billion by 2021 - Favorable Reimbursement Environment & Government Support Driving Growth

DUBLIN, July 4, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Pen Needles Market - Trends & Global Forecasts to 2021" report to their offering.

Over the years, the pen needles market has witnessed various technological advancements in order to cater to the growing demand for safety injections in the healthcare industry. These advancements have led to the development of safety pen needles with an aim to reduce pain, increase comfort, and most importantly reduce needlestick injuries (NSIs). Other factors contributing to the growth of the pen needles market include favorable reimbursement environment and government support in selected countries, advantages of insulin pens over syringes and vials, and growing diabetic population.

The insulin therapy segment is expected to dominate the pen needles market, by therapy, in 2016. Growth in the insulin therapy segment can be attributed to the increasing use of insulin by the diabetic population and increasing awareness about insulin self-administration among type 1 and type 2 diabetes patients.

Europe is expected to account for the largest share in the pen needles market in 2016, followed by North America, Asia, and the Rest of the World (RoW). The large share of the European region can be attributed to EU's Directive on the prevention of sharp injuries in hospitals and the healthcare sector; regulatory frameworks to minimize needlestick injuries & boost the use of safety-engineered devices; high diabetes prevalence and favorable reimbursement for pen needles in Germany; activities to pool funds for diabetes care & research in the U.K.; high insurance coverage and increase in aging population and affordability in France; awareness campaigns for diabetes in Italy; large pool of diabetic population and regulations mandating the use of safety pen needles in Spain; and high diabetes prevalence in Russia, Poland, Romania, and Ukraine.

Asia is expected to witness the highest growth rate in the forecast period, mainly due to the rapidly growing diabetic population, increasing awareness, and rising adoption of pen devices for insulin delivery.

Companies Mentioned:

• Allison Medical, Inc.
• Artsana S.P.A.
• B. Braun Melsungen
• Becton, Dickinson And Company
• Htl-Strefa S.A.
• Novo Nordisk A/S
• Owen Mumford, Ltd.
• Terumo Corporation
• Ultimed, Inc. (Ldi, Ltd.)
• Ypsomed Holding Ag

Key Topics Covered:

1 Introduction 

2 Research Methodology 

3 Executive Summary

4 Premium Insights

5 Market Overview 

6 Industry Insights

7 Pen Needles Market, By Type 

8 Pen Needles Market, By Needle Length 

9 Pen Needles Market, By Therapy

10 Pen Needles Market, By Mode Of Purchase

11 Pen Needles Market, By Region

12 Pen Needle Distributor List

13 Competitive Landscape

14 Company Profiles

For more information visit http://www.researchandmarkets.com/research/n3vzh3/pen_needles

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets